Deborah Gleeson

Dr. Deborah Gleeson


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Globalization and Health
Verified
Journal Article
Open access
PDF file
SFSharon Friel
Sharon Friel
DGDeborah Gleeson
Deborah Gleeson
ATAnne Marie Thow
Anne Marie Thow
RLRonald Labonte
Ronald Labonte
DSDavid Stuckler
David Stuckler
WSWendy Snowdon
Wendy Snowdon
Trade poses risks and opportunities to public health nutrition. This paper discusses the potential food-related public health risks of a radical new kind of trade agreement: the Trans Pacific Partnership agreement (TPP). Under negotiation since 2010, the TPP involves Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the USA, and Vietnam. Here, we review the international evidence on the relationships between trade agreements and diet-related health and, where available, documents and leaked text from the TPP negotiations. Similar to other recent bilateral or regional trade agreements, we find that the TPP would propose tariffs reductions, foreign investment liberalisation and intellectual property protection that extend beyond provisions in the multilateral World Trade Organization agreements. The TPP is also likely to include strong investor protections, introducing major changes to domestic regulatory regimes to enable greater industry involvement in policy making and new avenues for appeal. Transnational food corporations would be able to sue governments if they try to introduce health policies that food companies claim violate their privileges in the TPP; even the potential threat of litigation could greatly curb governments’ ability to protect public health. Hence, we find that the TPP, emblematic of a new generation of 21st century trade policy, could potentially yield greater risks to health than prior trade agreements. Because the text of the TPP is secret until the countries involved commit to the agreement, it is essential for public health concerns to be articulated during the negotiation process. Unless the potential health consequences of each part of the text are fully examined and taken into account, and binding language is incorporated in the TPP to safeguard regulatory policy space for health, the TPP could be detrimental to public health nutrition. Health advocates and health-related policymakers must be proactive in their engagement with the trade negotiations.

1 January 2015 in Health Policy
Verified
Journal Article
Closed access
ATAnne Marie Thow
Anne Marie Thow
WSWendy Snowdon
Wendy Snowdon
RLRonald Labonté
Ronald Labonté
DGDeborah Gleeson
Deborah Gleeson
DSDavid Stuckler
David Stuckler
SFSharon Friel
Sharon Friel

1 April 2013 in The Lancet
Verified
Journal Article
Closed access
DGDeborah Gleeson
Deborah Gleeson
SFSharon Friel
Sharon Friel

8 June 2023 in Health & Place
Verified
Journal Article
Open access
DGDeborah Gleeson
Deborah Gleeson
BTBelinda Townsend
Belinda Townsend
BTBrigitte F. Tenni
Brigitte F. Tenni
TPTarryn Phillips
Tarryn Phillips
This paper presents a political economy analysis of global inequities in access to COVID-19 vaccines, treatments, and diagnostic tests. We adapt a conceptual model used for analysing the political economy of global extraction and health to examine the politico-economic factors affecting access to COVID-19 health products and technologies in four interconnected layers: the social, political, and historical context; politics, institutions, and policies; pathways to ill-health; and health consequences. Our analysis finds that battles over access to COVID-19 products occur in a profoundly unequal playing field, and that efforts to improve access that do not shift the fundamental power imbalances are bound to fail. Inequitable access has both direct effects on health (preventable illness and death) and indirect effects through exacerbation of poverty and inequality. We highlight how the case of COVID-19 products reflects broader patterns of structural violence, in which the political economy is structured to improve and lengthen the lives of those in the Global North while neglecting and shortening the lives of those in the Global South. We conclude that achieving equitable access to pandemic response products requires shifting longstanding power imbalances and the institutions and processes that entrench and enable them.

24 June 2011 in Journal of Comparative Policy Analysis: Research and Practice
Verified
Journal Article
Open access
DGDeborah Gleeson
Deborah Gleeson
DLDavid Legge
David Legge
DODeirdre O'Neill
Deirdre O'Neill
MPMonica Pfeffer
Monica Pfeffer
This article explores how organizational policy capacity can be developed, drawing on a study conducted in a large human services agency in Australia. Building policy capacity within government agencies is widely acknowledged as important for successfully responding to complex policy problems. The existing literature suggests a range of strategies for building organizational capacity. Findings from interviews with policy workers support the principles for building policy capacity identified in the literature but uncovered a surprising degree of scepticism pointing to significant barriers to their realization. These barriers are identified as emerging out of the tensions between policy capacity and two other domains of governing capacity: administrative capacity and state capacity. These tensions however are highly contingent and dynamic; managing them requires a degree of discretion and judgement, in brief, policy leadership. A focus on developing policy leadership at the level of policy units and teams may present a strategic approach to building organizational capacity for policy work.

1 January 2013 in Journal of Law, Medicine & Ethics
Verified
Journal Article
Closed access
RLRuth Lopert
Ruth Lopert
DGDeborah Gleeson
Deborah Gleeson